tirzepatide effect on kidneys Long-Term Demonstrates Benefits in Patients With CKD, Obesity, and HFpEF The benefits and risks of
Description
Why am I not losing weight on Hers semaglutide

Four cases of neoplasm (0.5 mg semaglutide), a malignant neoplasm and a metastatic pancreatic cancer (1.0 mg semaglutide) was also reported [52]
The difference introduces considerable uncertainty in the comparison, but the results nonetheless suggest the two approaches are roughly similar in efficacy for weight loss
Ideal candidates for semaglutide weight loss treatment typically have a body mass index of 30 or higher or a BMI of 27 with weight-related health issues like high blood pressure or type 2 diabetes

Game-Changer in Obesity Care: FDA Approves First Oral Semaglutide Pill